Savara inc. (SVRA)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Cash flows from operating activities:
Net loss

-15,421

-31,719

-12,403

-21,939

-12,112

-10,514

-12,560

-11,593

-26,849

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-5,869

-6,035

-8,152

-10,706

-11,207

-10,163

-9,912

-10,151

-9,616

-7,313

-7,866

-7,152

-6,371

-5,704

-5,253

-4,941

-5,580

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

11

13

25

29

32

41

38

37

30

25

25

23

12

-

-

-

-

Depreciation and amortization including right-of-use assets

242

238

233

232

307

139

127

153

107

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9

Amortization of debt issuance costs and debt discount

-

-

-

-

-

-

-

-

-

-

-

-

104

62

615

163

169

-

-

-

-

-

-

-

-

-

-

-

-

Expenses related to options issued to non-employees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Expenses paid by issuance of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Expenses paid by issuance of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Expenses paid by issuance of preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Expenses related to stock warrants issued

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Equity in loss of investee

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Acquired in-process research and development (Note 7)

5,367

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Impairment of acquired IPR&D

-

-

-

-

-

0

0

0

21,692

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on bargain purchase

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Amortization of debt discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Forgiveness of employee receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Impairment of goodwill

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Changes in fair value of financial instruments

2

41

-136

-41

-77

-12

10

34

-96

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of contingent consideration

-

0

0

131

133

135

134

131

-134

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Noncash interest (income) expense

133

-114

111

-65

-4

-8

29

19

35

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign currency (gain) loss

156

-245

116

110

-59

-16

-7

155

-61

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt issuance costs

134

150

140

145

147

136

109

114

109

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accretion on discount to short-term investments

69

157

316

346

342

354

268

140

138

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation

1,194

1,149

1,145

1,147

1,000

945

1,988

392

412

202

114

-225

461

692

645

647

659

553

544

512

1,066

519

689

425

399

440

442

365

351

Loss on disposals of equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Loss on fair value of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Loss on change in fair value of contingent consideration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-7

-27

Gain on bargain purchase

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

33

453

-

-

-

-

Benefit for deferred taxes

-

-

-

-

-

-2,502

0

0

-4,555

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Write-off of license agreement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Impairment of equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Cumulative effect of change in accounting principle

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Amortization of premium / (accretion of discount) on investments in securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Changes in operating assets and liabilities:
Prepaid expenses and other current assets

195

246

-279

-46

-69

-1,324

143

335

-54

1,292

455

1,332

-515

-325

539

-424

-153

-264

127

562

-438

119

28

113

-202

580

-122

171

-140

Non-current assets

821

-803

-166

-115

953

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses and other current liabilities

-3,180

139

-712

188

953

155

1,835

110

-554

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term liabilities

-305

-

-76

90

-193

-

-10

-6

-7

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease in accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-127

-

-

-

-776

-

-

-

-

-

-

-

-

-

-

-

-

Increase/(decrease) in accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

1,726

-

-

-

-358

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,172

1,631

733

-

1,812

-139

-62

973

910

60

563

Net cash used in operating activities

-13,079

-9,946

-11,413

-12,905

-10,859

-10,493

-8,762

-10,349

-9,671

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,488

Cash flows from investing activities:
Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-3,179

-7,329

-10,969

-7,641

-11,328

-8,811

-8,256

-8,533

-7,349

-6,015

-5,368

-6,989

-6,273

-

-

-

-

Proceeds from sale of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Cash acquired through Merger

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

3,534

-

-

-

0

Purchases of certificates of deposit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,478

249

2,690

5,296

6,972

4,482

1,236

6,745

2,559

15,423

996

2,988

Proceeds from maturities of certificates of deposit

-

-

-

-

-

-

-

-

-

-

-

-

498

3,686

4,150

2,988

4,383

4,980

4,707

2,490

4,847

2,581

7,452

947

5,679

2,988

4,722

3,145

6,393

Proceeds from sales of certificates of deposit

-

-

-

-

-

-

-

-

-

-

-

-

2,241

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Security deposit for sublease

-

-

-

-

-

-

-

-

-

-

-

-

90

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of other investment securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from maturities and sales of other investment securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Purchase of property and equipment

4

10

6

36

96

60

16

46

19

-

-

-

-

0

1

2

5

47

27

21

70

10

28

103

6

1

28

12

4

Purchase in-process research and development (Note 7)

3,247

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of available-for-sale securities, net

35,614

18,741

12,006

46,163

46,035

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of available-for-sale securities, net

-

-

-

-

-

-

-

-

15,891

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Maturities of available-for-sale securities

31,300

35,500

18,600

27,800

42,800

34,400

24,846

14,200

25,300

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Sale of available-for-sale securities, net

5,780

2

2

3,478

10,651

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments made on debt facility

-

-

-

-

-

-

-

-

-

-

-

-

368

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Costs paid in connection with debt facility

-

-

-

-

-

-

-

-

-

-

-

-

50

0

76

9

38

-

-

-

-

-

-

-

-

-

-

-

-

Payment on obligation under license agreement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Issuance of note receivable - related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Payments on note receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Advance to investee

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Cash transferred in rescission of acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Cash received in rescission of acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net cash (used in) provided by investing activities

-1,785

16,751

6,590

-14,921

7,320

869

-35,712

11,834

9,390

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,400

Cash flows from financing activities:
Net cash provided by / (used in) investing activities

-

-

-

-

-

-

-

-

-

-

-

-

2,829

3,686

4,149

2,986

4,378

-296

4,431

-221

-519

-4,401

2,812

-392

2,462

-

-

-

-

Issuance of common stock upon exercise of warrants

-

-

-

-

-

0

0

1

18

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of common stock upon at the market offerings, net

-

1

5,664

19,037

4,890

12

0

0

493

-

-

-

-

2,016

3,909

5,973

8,060

0

0

2,131

9

15,435

2,292

4,180

8,294

0

0

28,097

0

Repayment of debt facility

514

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from exercise of stock options

48

-1

44

61

6

8

17

30

3

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from sale or exercise of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from sale of preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Repurchase of Subject to Vesting Shares

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Repurchase of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Payments for offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

56

94

338

601

13

20

96

13

1,341

122

279

316

116

242

2,001

0

Capital lease obligation principal payments

-

-

-

-

-

289

-1

15

243

0

455

2

3

2

2

2

2

2

2

1

2

-

-

-

0

-

-

-

-

Proceeds from issuance of notes payable and detachable warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Cash paid in lieu of fractional shares for reverse stock split

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net cash (used in) provided by financing activities

-466

25,248

5,708

19,056

4,896

9,096

45,810

16

271

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Effect of exchange rate changes on cash and cash equivalents

41

-34

70

-71

13

-117

6

-19

11

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in cash and cash equivalents

-15,289

32,019

955

-8,841

1,370

-645

1,342

1,482

1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-421

-8,336

2,851

5,624

7,419

-48

14,818

2,034

-6

20,242

2,170

3,901

7,978

-

-

-

-

Effect of exchange rate changes on cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

-0

1

-2

Increase / (Decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

48,531

-771

-11,979

-3,969

969

469

-9,155

10,993

-6,720

-7,874

9,826

-386

-3,480

4,167

-4,549

-14,741

23,562

-1,090

Non-cash transactions
Acquisition of in-process research and development (Note 7)

-2,120

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental disclosure of cash flow information:
Cash paid for interest and end of period charge due upon debt facility amendment

990

-

-

-

528

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for interest

-

-

-

-

-

368

353

351

334

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-